Form 4: ICU Medical Inc. Executive Virginia Sanzone Reports Stock Transactions
SEC Form 4 Filing
Virginia Sanzone, VP and General Counsel of ICU Medical Inc., reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.
Summary
- On March 15, 2025, Virginia Sanzone, VP and General Counsel of ICU Medical Inc., reported transactions involving ICU Medical Inc. common stock.
- Specifically, 1,624 Restricted Stock Units (RSUs) vested and were converted into common stock.
- Simultaneously, 898 shares were disposed of at a price of $143.45 to satisfy tax withholding obligations.
- Following these transactions, Sanzone directly owns 7,086 shares of common stock and 1,624 derivative securities (RSUs).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor executive compensation and potential alignment with shareholder interests.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning executive incentives with long-term company performance.
- The disposal of shares to cover tax obligations upon vesting is a common practice among executives receiving equity compensation.
- Comparing Sanzone's holdings and transactions to those of executives at similar medical device companies (e.g., Medtronic, Stryker) could provide context on the scale of her equity compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, or creditors.
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/15/2023 | Date the restricted stock units were legally granted. |
| 05/17/2023 | Date of shareholder approval for the restricted stock units. |
| 03/15/2025 | Date of transaction: Vesting of RSUs and disposal of shares for tax obligations. |
| 03/15/2026 | Expiration date of the derivative security. |
| 03/17/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.